LECAP Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,264
Closed -$1.68M 394
2024
Q3
$1.68M Sell
11,264
-1,767
-14% -$253K 0.36% 105
2024
Q2
$1.64M Buy
+13,031
New +$2.04M 0.35% 107
2024
Q1
Sell
-1,340
Closed -$241K 369
2023
Q4
$241K Buy
+1,340
New +$209K 0.09% 270

Other funds holding RGEN

LECAP Asset Management's RGEN Position: Q4 2024 in Review

LECAP Asset Management sold out of Repligen (RGEN) in Q4 2024, closing a stake of 11,264 shares — an estimated $1.68M sold.

LECAP Asset Management first reported a position in RGEN in Q4 2023 and held it in 3 quarters. The position peaked at $1.68M in Q3 2024. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

  • LECAP Asset Management reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
  • LECAP Asset Management sold 11,264 Repligen shares in Q4 2024, an estimated $1.68M.
  • LECAP Asset Management first reported a position in Repligen in Q4 2023 and held it in 3 quarters.
  • LECAP Asset Management's Repligen position peaked at $1.68M in Q3 2024.
  • 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on LECAP Asset Management's 13F filing for Q4 2024, filed 28 Jan 2025.